The article comments on the paper "Postoperative Radiation Therapy for Lung Cancer: Where Do We Stand?," by Chris R. Kelsey and colleagues. The failure of postoperative radiation therapy (PORT) to improve survival in lung cancer patients may be due to the toxicity and comorbidy challenges. The use of PORT for non-small-cell lung cancer will remain a controversial topic in thoracic oncology.